Company intelligence / Profile preview

ClearFlow

Ownership: Private
Employees: ~33
Development stage: Other

Overview

ClearFlow’s PleuraFlow Active Clearance Technology System is a patented device designed to prevent chest tube occlusion following heart, lung, and trauma surgeries. Clinical studies have shown it reduces the need for re-intervention due to retained blood syndrome by up to 43% and decreases post-operative atrial fibrillation by one-third. The system is approved in the US, Europe, Australia, Brazil, Canada, and other countries. It has won multiple innovation awards for its impact on patient outcomes after cardiothoracic surgery

Therapeutic areas: CardiovascularOther
Modalities: Device (Active Clearance Technology System for surgical drainage)
Industry: Therapeutic Medical Devices

Partnerships

Maquet Medical/Getinge Group (exclusive U.S. marketing deal for PleuraFlow)

Beyond the preview

Go deeper on ClearFlow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClearFlow.

Explore the full profile